About Phathom Pharma (PHAT)
Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more
- USD9.01
- USD9.18
- USD8.83
- USD17.02
- 4.10%
- 1M
- 862.09k
- 525M
- 6.07
- -16.30%
Stock News
1 hour ago
Forget SoundHound AI: 3 Tech Stocks to Buy Instead
Yahoo
1 hour ago
This Is Hands Down My Pick for the Best "Magnificent Seven" Stock Right Now. (Hint: It's Not Nvidia.)
Yahoo
2 hours ago
Swipe Right on Safety: New Study from Norton Finds 64% of Online Daters are Interested in Using AI as a Dating Coach
Yahoo
2 hours ago
JD Sports Fashion Buys Hibbett, Valuing It at $1.1 Bln, in Push Into U.S. Market
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
